On May 29, 2024, Stewart Strong, President of Global Hospital at Haemonetics Corp (NYSE:HAE), sold 8,857 shares of the company.
On May 29, 2024, Michelle Basil, Executive Vice President and General Counsel of Haemonetics Corp (NYSE:HAE), executed a sale of 12,990 shares of the company at a price of $88.08 per share.
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.